tm logo
VERZZENIOS
REGISTERED

on 28 Jun 2019

Last Applicant/ Owned by

ELI LILLY AND COMPANY

Lilly Corporate CentreIndianapolis, IN 46285

US

Serial Number

1762833 filed on 11th Jan 2016

Registration Number

TMA1033779 registered on 28th Jun 2019

Registration expiry Date

28th Jun 2029

Correspondent Address

World Exchange Plaza100 Queen Street, Suite 1300Ottawa

ONTARIO

CA

K1P1J9

VERZZENIOS

Trademark usage description

pharmaceutical preparations, namely, pharmaceutical preparations for the diagnosis and treatment of alcohol use disorders, alzheimer's, anxiety disord Read More

Classification Information


Class [005]
Pharmaceutical preparations, namely, pharmaceutical preparations for the diagnosis and treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, hormonal diseases and disorders, namely vasomotor symptoms and hot flashes, inflammation and inflammatory diseases and disorders, namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, namely metabolic syndrome, migraines, muscle diseases and disorders, namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders, namely Huntington's disease, Alzheimer's disease, Dementia and Parkinson's disease, neurological disorders namely, Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, pain relief, pancreatic diseases and disorders, psychiatric disorders, namely acute stress disorder, substance abuse, delusions and hallucinations, sleep disorders, urological disorders; antipsychotic pharmaceutical preparations; antidepressants; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases


Classification kind code

10

Mark Details


Serial Number

1762833

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 50
on 04th Nov 2016
Allowed
Submitted for opposition 51
on 04th Nov 2016
Allowance Notice Sent
Submitted for opposition 42
on 20th Jul 2016
Advertised
Submitted for opposition 26
on 30th Jun 2016
Approved
Submitted for opposition 27
on 11th May 2016
Approval Notice Sent
Submitted for opposition 22
on 07th Apr 2016
Search Recorded
Submitted for opposition 20
on 07th Apr 2016
Examiner's First Report
Submitted for opposition 31
on 13th Jan 2016
Formalized
Submitted for opposition 1
on 12th Jan 2016
Created
Submitted for opposition 30
on 11th Jan 2016
Filed